• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌筛查的收益:观察性数据的重要性及偏倚问题]

[The yield of breast cancer screening: the importance of observational data and the problems of bias].

作者信息

Giard R W

机构信息

Medisch Centrum Rijnmond-Zuid, locatie St. Clara, afd. Klinische Pathologie, Postbus 9119, 3007 AC Rotterdam.

出版信息

Ned Tijdschr Geneeskd. 2004 Feb 21;148(8):352-5.

PMID:15032087
Abstract

Descriptive studies are important for the analysis of the effects of medical interventions. Especially in breast cancer screening, where the balance between gains and losses is often difficult to establish, detailed, empirical, long-term follow-up data on outcomes are of vital importance. Recent Dutch data comparing the prognosis, tumour stage at diagnosis and surgical treatment before and after the introduction of a population-based breast cancer screening programme reveal a better prognosis and a more favourable tumour stage after introduction of the programme. However, these data have their limitations. The interpretation of such figures is hampered by different types of bias (lead-time, length and over-diagnosis). The final assessment is always subjective and prone to confirmation bias.

摘要

描述性研究对于分析医学干预措施的效果很重要。特别是在乳腺癌筛查中,收益与损失之间的平衡往往难以确定,关于结局的详细、实证性、长期随访数据至关重要。荷兰最近的数据比较了基于人群的乳腺癌筛查计划实施前后的预后、诊断时的肿瘤分期和手术治疗情况,结果显示该计划实施后预后更好,肿瘤分期更有利。然而,这些数据有其局限性。此类数据的解读受到不同类型偏差(领先时间、病程和过度诊断)的阻碍。最终评估始终是主观的,且容易出现确认偏差。

相似文献

1
[The yield of breast cancer screening: the importance of observational data and the problems of bias].[乳腺癌筛查的收益:观察性数据的重要性及偏倚问题]
Ned Tijdschr Geneeskd. 2004 Feb 21;148(8):352-5.
2
Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.丹麦三十年乳腺癌发展趋势:诊断分期、手术治疗与生存情况
Acta Oncol. 2008;47(4):537-44. doi: 10.1080/02841860801982758.
3
Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?近期乳腺钼靶筛查结果为阴性的女性中的晚期乳腺癌:临床诊疗是否提供了早期检测的机会?
J Natl Cancer Inst Monogr. 2005(35):39-46. doi: 10.1093/jncimonographs/lgi036.
4
Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.在评估乳腺钼靶筛查中减少领先时间偏倚、长度偏倚和过度检测的影响:一种删失双变量数据方法
Stat Methods Med Res. 2008 Dec;17(6):643-63. doi: 10.1177/0962280207087309. Epub 2008 Apr 29.
5
Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.少数病例报告——因乳腺钼靶筛查可疑而被召回的女性中乳腺评估假阴性:影像学和病理特征以及相关诊断延迟
Breast Cancer Res Treat. 2007 Sep;105(1):37-43. doi: 10.1007/s10549-006-9425-3. Epub 2006 Nov 18.
6
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.考虑到提前期和长度偏倚,对筛查发现的和有症状的乳腺癌女性的生存情况进行人群估计。
Breast Cancer Res Treat. 2009 Jul;116(1):179-85. doi: 10.1007/s10549-008-0100-8. Epub 2008 Jul 12.
7
Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.乳腺癌发病率处于中等水平且呈上升趋势的国家中乳腺癌筛查的演变
J Med Screen. 2006;13 Suppl 1:S23-7.
8
Early diagnosis, not differential treatment, explains better survival in service screening.早期诊断而非差异化治疗,能更好地解释服务筛查中生存率较高的原因。
Eur J Cancer. 2005 Nov;41(17):2728-34. doi: 10.1016/j.ejca.2005.06.026. Epub 2005 Oct 18.
9
[Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].[德国癌症流行病学登记处对乳腺X线筛查评估的贡献]
Gesundheitswesen. 2005 Jul;67(7):448-54. doi: 10.1055/s-2005-858515.
10
Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?在丹麦和瑞典,确诊时的分期能否解释乳腺癌患者生存情况的差异?
Acta Oncol. 2004;43(8):719-26. doi: 10.1080/02841860410002789.